124 related articles for article (PubMed ID: 749193)
1. [Simultaneous hormonal and drug therapy, compared to hormonal therapy, followed by chemotherapy, in the treatment of metastasizing breast neoplasms. Preliminary results of an ongoing study].
Cavalli F; Alberto P; Jungi WF; Martz G; Barrelet L; Obrecht JP; Brunner KW
Schweiz Med Wochenschr; 1978 Dec; 108(49):1964-6. PubMed ID: 749193
[TBL] [Abstract][Full Text] [Related]
2. [Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer].
Cavalli F; Beer M; Martz G; Jungi WF; Alberto P; Obrecht JP; Mermillod B; Brunner KW
Schweiz Med Wochenschr; 1982 May; 112(22):774-83. PubMed ID: 7048518
[TBL] [Abstract][Full Text] [Related]
3. Management of breast cancer.
Cohen IA; Keller JH; Abate MA
Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
[TBL] [Abstract][Full Text] [Related]
4. [Endocrine therapy of recurrent breast cancer].
Nomura Y; Tashiro H
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.
Wendt AG; Jones SE; Salmon SE
Cancer Treat Rep; 1980; 64(2-3):269-73. PubMed ID: 6893293
[TBL] [Abstract][Full Text] [Related]
6. [Review of adjuvant breast cancer therapy in non-menopausal women including early results of medical castration with LH-RH analogs].
Namer M; Ramaioli A
Bull Cancer; 2000 Feb; 87(2):139-44. PubMed ID: 10705284
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen therapy of metastatic breast cancer.
Manni A
J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
[TBL] [Abstract][Full Text] [Related]
10. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
[TBL] [Abstract][Full Text] [Related]
11. Hormonal approaches to breast cancer treatment and prevention: an overview.
Vogel CL
Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
[TBL] [Abstract][Full Text] [Related]
12. A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.
Assikis V; Buzdar A; Yang Y; Smith T; Theriault R; Booser D; Valero V; Walters R; Singletary E; Ames F; Hortobagyi G
Cancer; 2003 Jun; 97(11):2716-23. PubMed ID: 12767083
[TBL] [Abstract][Full Text] [Related]
13. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
[No Abstract] [Full Text] [Related]
14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
15. [Medical therapy of the metastasizing breast neoplasm].
Hartenstein R; Ehrhart H; Pape W
Fortschr Med; 1977 May; 95(19):1305-12. PubMed ID: 863373
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
[TBL] [Abstract][Full Text] [Related]
17. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
18. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
[TBL] [Abstract][Full Text] [Related]
19. [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].
Martin PM; Romain S; Spyratos F; Spitalier JM; Ayme Y; Brandone H; Bressac C; Hans D; Jacquemier J; Hacene K
Bull Cancer; 1991; 78(8):709-23. PubMed ID: 1932838
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy of breast cancer.
Crown J; Raptis G; Hamilton N; Hudis C; Vahclat L; Fennelly D; Norton L
Can J Oncol; 1995 Dec; 5 Suppl 1():80-2. PubMed ID: 8853530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
